Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

ConditionTumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer

Eligibility criteria

Qualifiers

Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.

Age ≥ 18 years

Plan to obtain the majority of treatment at MDACC including surgery and radiotherapy

Ability to understand and willingness to sign written informed consent

Disqualifiers

History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.

Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.

Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.

Trial design

Treatments tested in this trial

  • Standard of Care

Treatment groups

No treatment groups listed

Sponsors and collaborators